Eli Lilly and Company Press Releases

LLY 
$84.05
*  
0.09
0.11%
Get LLY Alerts
*Delayed - data as of Aug. 4, 2015  -  Find a broker to begin trading LLY now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study
8/4/2015 5:06:00 PM - PR Newswire
unchange Price Change since this news event. The Volume Ratio is 0.19.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly Provides Update on Evacetrapib Phase 3 Trial
7/27/2015 8:00:00 AM - PR Newswire
▼-0.79 % Price Change since this news event. The Volume Ratio is 0.78.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly Diabetes and NASCAR XFINITY Series Driver Ryan Reed Want You to Think About Your Diabetes Pit Crew
7/23/2015 12:04:00 PM - PR Newswire
▼-2.34 % Price Change since this news event. The Volume Ratio is 0.71.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Eli Lilly and Company Announces Expansion of San Diego Biotechnology Center
7/23/2015 6:32:00 AM - PR Newswire
▼-3.62 % Price Change since this news event. The Volume Ratio is 0.78.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly Reports Second-Quarter 2015 Results, Revises 2015 Financial Guidance
7/23/2015 6:25:00 AM - PR Newswire
▼-3.62 % Price Change since this news event. The Volume Ratio is 0.78.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


New Study Shows Florbetapir F 18 Injection Scans Led to Change in Diagnosis and Management of Patients Being Evaluated for Cognitive Decline
7/22/2015 12:00:00 PM - PR Newswire
▼-1.52 % Price Change since this news event. The Volume Ratio is 1.08.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Data Using New Delayed-Start Methodology Suggested Benefit of Early Treatment with Solanezumab in Patients with Mild Alzheimer's Disease
7/22/2015 7:00:00 AM - PR Newswire
▼-2.83 % Price Change since this news event. The Volume Ratio is 2.35.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Lilly Diabetes Launches Android Version of Glucagon Mobile Application for Those Who Support People with Diabetes
7/14/2015 3:00:00 PM - PR Newswire
▼-5.18 % Price Change since this news event. The Volume Ratio is 1.13.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly Statement on FDA Advisory Committee Review of Necitumumab
7/9/2015 1:55:00 PM - PR Newswire
▼-3.82 % Price Change since this news event. The Volume Ratio is 0.94.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly Confirms Date and Conference Call for Second-Quarter 2015 Financial Results Announcement
7/1/2015 1:30:00 PM - PR Newswire
▼-0.52 % Price Change since this news event. The Volume Ratio is 0.96.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma
6/29/2015 8:00:00 AM - PR Newswire
▼-1.67 % Price Change since this news event. The Volume Ratio is 0.92.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Immunocore and Lilly Announce Immunotherapy-Based Clinical Trial Collaboration in Melanoma
6/29/2015 2:00:00 AM - Business Wire
▼-1.67 % Price Change since this news event. The Volume Ratio is 0.89.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Adocia and Lilly report positive Phase 1b topline results on the post-meal effect of ultra-rapid BioChaperone Lispro in patients with type 1 diabetes
6/26/2015 1:30:00 AM - Business Wire
▼-1.28 % Price Change since this news event. The Volume Ratio is 1.49.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Diabetes Scholars Foundation Announces 2015 Scholarship Recipients
6/25/2015 9:00:00 AM - PR Newswire
▲0.06 % Price Change since this news event. The Volume Ratio is 2.24.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


UK Court Rules in Favor of Lilly in Alimta Vitamin Regimen Patent Lawsuit
6/25/2015 6:00:00 AM - PR Newswire
▲2.18 % Price Change since this news event. The Volume Ratio is 2.24.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


CYRAMZA® (ramucirumab) Hepatocellular Carcinoma Data Published by The Lancet Oncology
6/19/2015 8:00:00 AM - PR Newswire
▲1.22 % Price Change since this news event. The Volume Ratio is 0.97.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly's investigational medicine for prevention of migraine met primary endpoint in a Phase 2b study
6/17/2015 12:00:00 PM - PR Newswire
▲0.17 % Price Change since this news event. The Volume Ratio is 0.56.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Eli Lilly and Company Enters Into Strategic Partnership with Sarah Cannon Research Institute to Develop Investigational Oncology Therapy
6/17/2015 8:01:00 AM - PR Newswire
▼-1.01 % Price Change since this news event. The Volume Ratio is 0.57.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly and Dana-Farber Cancer Institute Announce Research Collaboration
6/17/2015 8:00:00 AM - PR Newswire
▼-1.01 % Price Change since this news event. The Volume Ratio is 0.57.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly Declares Third-Quarter 2015 Dividend
6/15/2015 4:01:00 PM - PR Newswire
▲0.06 % Price Change since this news event. The Volume Ratio is 0.5.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly Announces Webcast to Discuss Ixekizumab Phase III Data
6/11/2015 2:00:00 PM - PR Newswire
▼-0.59 % Price Change since this news event. The Volume Ratio is 3.77.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Studies Show Psoriasis Patients Achieved Significant Levels of Skin Clearance and Improved Quality of Life after 12 Weeks of Ixekizumab Treatment
6/10/2015 12:04:00 PM - PR Newswire
▲2.14 % Price Change since this news event. The Volume Ratio is 1.92.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly and Incyte unveil detailed data on two pivotal studies of baricitinib in rheumatoid arthritis
6/10/2015 8:00:00 AM - PR Newswire
▲2.48 % Price Change since this news event. The Volume Ratio is 2.8.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Olympian Kris Freeman and NASCAR Driver Ryan Reed to Share Their Courageous Stories with Children Who Have Type 1 Diabetes
6/8/2015 1:30:00 PM - PR Newswire
▲6.88 % Price Change since this news event. The Volume Ratio is 2.51.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day